News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
171,858 Results
Type
Article (12712)
Company Profile (23)
Press Release (159123)
Section
Business (48410)
Career Advice (606)
Deals (9069)
Drug Delivery (28)
Drug Development (27858)
Employer Resources (69)
FDA (4631)
Job Trends (3839)
News (90585)
Policy (7770)
Tag
Academia (1061)
Alliances (13524)
Alzheimer's disease (398)
Approvals (4611)
Artificial intelligence (35)
Bankruptcy (68)
Best Places to Work (3173)
Breast cancer (38)
Cancer (280)
Cardiovascular disease (27)
Career advice (506)
Cell therapy (53)
Clinical research (23171)
Collaboration (92)
COVID-19 (1064)
Data (335)
Diabetes (53)
Diagnostics (1592)
Diversity, equity & inclusion (28)
Drug pricing (29)
Earnings (13938)
Employer resources (63)
Events (20366)
Executive appointments (83)
FDA (4758)
Funding (95)
Gene therapy (50)
GLP-1 (227)
Government (1143)
Healthcare (5347)
Infectious disease (1094)
Inflammatory bowel disease (41)
Interviews (102)
IPO (3395)
Job creations (772)
Job search strategy (449)
Layoffs (70)
Legal (1511)
Lung cancer (44)
Manufacturing (44)
Medical device (3111)
Medtech (3113)
Mergers & acquisitions (5721)
Metabolic disorders (123)
Neuroscience (490)
NextGen Class of 2024 (1991)
Non-profit (1625)
Northern California (287)
Obesity (64)
Opinion (40)
Parkinson's disease (26)
People (16976)
Phase I (5152)
Phase II (9957)
Phase III (9427)
Pipeline (121)
Policy (29)
Postmarket research (1142)
Preclinical (1857)
Press Release (29)
Radiopharmaceuticals (62)
Rare diseases (57)
Real estate (1370)
Regulatory (5489)
Research institute (892)
Resumes & cover letters (82)
Southern California (274)
Startups (1174)
United States (2820)
Vaccines (241)
Weight loss (49)
Date
Today (35)
Last 7 days (174)
Last 30 days (796)
Last 365 days (8464)
2024 (7629)
2023 (9580)
2022 (12871)
2021 (14466)
2020 (14041)
2019 (13513)
2018 (10431)
2017 (9480)
2016 (9131)
2015 (10801)
2014 (7356)
2013 (5763)
2012 (6225)
2011 (6605)
2010 (5694)
Location
Africa (249)
Arizona (29)
Asia (12273)
Australia (2348)
California (657)
Canada (244)
China (72)
Colorado (32)
Connecticut (31)
Europe (32656)
Florida (87)
Georgia (43)
Illinois (91)
Indiana (50)
Japan (29)
Kansas (25)
Maryland (144)
Massachusetts (437)
Michigan (27)
Minnesota (62)
New Jersey (232)
New York (274)
North Carolina (139)
Northern California (287)
Pennsylvania (182)
South America (370)
Southern California (274)
Texas (77)
Washington State (117)
171,858 Results for "emmes group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
ILiAD Biotechnologies Announces Planned Collaboration with Emmes Group, a New Mountain Capital Portfolio Company, to Conduct Upcoming Phase III Clinical Trials of BPZE1, the Leading Next-Generation Pertussis Vaccine
ILiAD Biotechnologies, LLC today announced the selection of Emmes Group, a global contract research and technology organization, to conduct upcoming Phase III studies of its lead pertussis vaccine candidate, BPZE1. ILiAD and Emmes Group are currently working to finalize the definitive agreement.
June 24, 2024
·
4 min read
Press Releases
Emmes awarded multi-task, IDIQ contract with $50M ceiling, to support NIDA’s clinical trials network
September 4, 2024
·
2 min read
Emmes Acquires VaxTRIALS
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation
October 5, 2023
·
3 min read
Business
Emmes Appoints Peter Ronco as Chief Executive Officer
Emmes today announced that Peter Ronco has been named Chief Executive Officer, effective immediately.
September 20, 2023
·
3 min read
Press Releases
Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group’s Stake in PsyLabs
October 31, 2024
·
8 min read
Press Releases
Esaote Group expands production in India
November 6, 2024
·
2 min read
Press Releases
Stevanato Group to Present at Upcoming Investor Conferences
November 11, 2024
·
1 min read
Press Releases
Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit
October 9, 2024
·
1 min read
BioCapital
Matt Bond Has Joined Emmes as Chief Financial Officer
Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced that Matt Bond has become its chief financial officer.
October 3, 2023
·
2 min read
LSL Pharma Group Completes the Acquisition of Virage Santé
LSL PHARMA GROUP INC., a Canadian integrated pharmaceutical company, is pleased to announce the completion of the acquisition of Virage Santé, a company specializing in the manufacturing and marketing of natural health products, based in Lévis, Quebec.
June 18, 2024
·
3 min read
1 of 17,186
Next
